Pubblicazioni

Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis

2019 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pavel, A. B.; Song, T.; Kim, H. -J.; Del Duca, E.; Krueger, J. G.; Dubin, C.; Peng, X.; Xu, H.; Zhang, N.; Estrada, Y. D.; Denis, L.; Rao, N.; Gupta, S.; Zammit, D. J.; Bissonnette, R.; Guttman-Yassky, E.